In Committee
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
Sponsor
Rep. Dunn, Neal P. [R-FL-2]Republican · FloridaCommittee
Energy and Commerce CommitteeLast action
Referred to the House Committee on Energy and Commerce.
Mar 4, 2025
Referred to the House Committee on Energy and Commerce. · Mar 4, 2025
Introduced Mar 4, 2025
Members signed on after the sponsor
Offered against this measure
No roll calls stored
19 organizations reported lobbying on this bill, through 6 lobbying firms.
From Lobbying Disclosure Act reports that name this bill. Reports do not say how much of a quarter's spending went to any one bill, so none is attributed here.